Nuo Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2013 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Nuo Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2013 to Q2 2025.
  • Nuo Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $23.2K, a 653% increase year-over-year.
  • Nuo Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $93K, a 303% increase year-over-year.
  • Nuo Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $56.7K, a 161% increase from 2023.
  • Nuo Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $21.7K, a 138% increase from 2022.
  • Nuo Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9.15K.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $93K $23.2K +$20.1K +653% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-31
Q1 2025 $72.9K $19.3K +$16.3K +528% Jan 1, 2025 Mar 31, 2025 10-Q 2025-04-30
Q4 2024 $56.7K $29.6K +$24.2K +450% Oct 1, 2024 Dec 31, 2024 10-K 2025-04-01
Q3 2024 $32.5K $20.9K +$9.39K +81.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $23.1K $3.08K +$661 +27.3% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-31
Q1 2024 $22.4K $3.08K +$661 +27.3% Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-30
Q4 2023 $21.7K $5.38K +$11.6K Oct 1, 2023 Dec 31, 2023 10-K 2025-04-01
Q3 2023 $10.1K $11.5K +$10.1K +703% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $43.00 $2.42K -$5.09K -67.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $5.14K $2.42K -$4.01K -62.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $9.15K -$6.23K -$6.23K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-19
Q3 2022 $15.4K $1.44K +$1.44K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 $13.9K $7.51K +$7.51K Apr 1, 2022 Jun 30, 2022 10-Q/A 2022-08-10
Q1 2022 $6.43K $6.43K +$6.43K Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $0 $0 Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $0 $0 Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-08-10
Q1 2021 $0 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-K 2022-04-15
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-K 2022-04-15
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-K 2022-04-15
Q3 2014 $391K +$241K +160% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-13
Q2 2014 $371K +$152K +69.5% Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-14
Q3 2013 $150K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $219K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.